The Cigna Group (NYSE:CI) Shares Purchased by Choreo LLC

Choreo LLC boosted its stake in The Cigna Group (NYSE:CI) by 565.8% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,806 shares of the health services provider’s stock after buying an additional 9,183 shares during the quarter. Choreo LLC’s holdings in The Cigna Group were worth $3,529,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of CI. Norges Bank acquired a new position in The Cigna Group during the fourth quarter worth about $1,006,348,000. Vanguard Group Inc. boosted its holdings in shares of The Cigna Group by 8.1% during the 1st quarter. Vanguard Group Inc. now owns 26,793,138 shares of the health services provider’s stock worth $9,731,000,000 after purchasing an additional 2,017,333 shares during the last quarter. Price T Rowe Associates Inc. MD grew its position in shares of The Cigna Group by 6.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 14,341,233 shares of the health services provider’s stock valued at $5,208,593,000 after purchasing an additional 867,180 shares in the last quarter. Focused Investors Fund L P acquired a new stake in shares of The Cigna Group in the first quarter valued at approximately $205,529,000. Finally, Swedbank AB purchased a new position in The Cigna Group during the first quarter worth approximately $161,300,000. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts have issued reports on CI shares. Baird R W upgraded The Cigna Group to a “strong-buy” rating in a report on Thursday, May 30th. Piper Sandler initiated coverage on shares of The Cigna Group in a report on Wednesday, June 26th. They issued an “overweight” rating and a $400.00 price objective for the company. Robert W. Baird began coverage on shares of The Cigna Group in a research note on Thursday, May 30th. They set an “outperform” rating and a $388.00 target price on the stock. Royal Bank of Canada reiterated an “outperform” rating and issued a $384.00 target price on shares of The Cigna Group in a report on Monday. Finally, Stephens restated an “overweight” rating and set a $410.00 price target on shares of The Cigna Group in a report on Friday, August 2nd. One analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average target price of $387.00.

Insiders Place Their Bets

In other The Cigna Group news, Director William J. Delaney III sold 2,691 shares of the business’s stock in a transaction on Monday, August 19th. The shares were sold at an average price of $342.68, for a total value of $922,151.88. Following the completion of the transaction, the director now owns 17,539 shares in the company, valued at $6,010,264.52. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, Director William J. Delaney III sold 2,691 shares of The Cigna Group stock in a transaction dated Monday, August 19th. The stock was sold at an average price of $342.68, for a total value of $922,151.88. Following the completion of the transaction, the director now owns 17,539 shares in the company, valued at approximately $6,010,264.52. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Brian C. Evanko sold 4,795 shares of the business’s stock in a transaction dated Monday, June 24th. The stock was sold at an average price of $345.01, for a total value of $1,654,322.95. Following the transaction, the insider now directly owns 39,923 shares of the company’s stock, valued at $13,773,834.23. The disclosure for this sale can be found here. Insiders have sold a total of 9,033 shares of company stock worth $3,095,820 in the last ninety days. 0.60% of the stock is owned by corporate insiders.

The Cigna Group Trading Up 1.2 %

CI opened at $357.61 on Tuesday. The Cigna Group has a 52 week low of $253.95 and a 52 week high of $370.64. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.73. The business has a fifty day simple moving average of $341.24 and a 200-day simple moving average of $343.72. The firm has a market cap of $99.97 billion, a P/E ratio of 29.36, a P/E/G ratio of 1.08 and a beta of 0.50.

The Cigna Group (NYSE:CI) last announced its earnings results on Thursday, August 1st. The health services provider reported $6.72 EPS for the quarter, beating analysts’ consensus estimates of $6.42 by $0.30. The company had revenue of $60.52 billion during the quarter, compared to analysts’ expectations of $58.30 billion. The Cigna Group had a return on equity of 17.83% and a net margin of 1.70%. The Cigna Group’s revenue for the quarter was up 24.6% on a year-over-year basis. During the same period last year, the business posted $6.13 EPS. On average, equities analysts expect that The Cigna Group will post 28.48 earnings per share for the current year.

The Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 19th. Investors of record on Wednesday, September 4th will be paid a dividend of $1.40 per share. This represents a $5.60 annualized dividend and a yield of 1.57%. The ex-dividend date is Wednesday, September 4th. The Cigna Group’s payout ratio is currently 45.98%.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.